StockData
Curis Inc logo

Curis Inc (CRIS) stock

CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3092% below fair value
$0.54+0.11 (+24.32%)

Close on Nov 17, 2026Market cap $1.13MP/E –Yield –

Curis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Curis's pe ratio was 129.7× on Jan 31, 2013.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2013Jan 31, 2013129.7×−10.2
2012Dec 31, 2012139.9×–

More Curis figures

See a number that looks wrong?